The indications for the use of GLP1-RA in the study included weight loss (n=117, 70%), diabetes (n=46, 28%) and other indications (n=4, 2%) such as PCOS, dumping syndrome or metabolic syndrome (online supplemental figure 1). The gene discussed is GLP1R; the disease is metabolic syndrome.